Dysregulation of immunoproteasomes in autoinflammatory syndromes

International Immunology
Koji Yasutomo

Abstract

Immunoproteasomes degrade ubiquitin-coupled proteins and play a role in creating peptides for presentation by MHC class I proteins. Studies of gene-deficient mice, in which each immunoproteasomal subunit was affected, have demonstrated that dysfunction of immunoproteasomes leads to immunodeficiency, i.e. reduced expression of MHC class I and attenuation of CD8 T-cell responses. Recent studies, however, have uncovered a new type of autoinflammatory syndrome characterized by fever, nodular erythema and progressive partial lipodystrophy that is caused by genetic mutations in immunoproteasome subunits. These mutations disturbed the assembly of immunoproteasomes, which led to reduced proteasomal activity and thus accumulation of ubiquitin-coupled proteins. Those findings suggest that immunoproteasomes function as anti-inflammatory machinery in humans. The discovery of a new type of autoinflammatory syndrome caused by dysregulated immunoproteasomes provides novel insights into the important roles of immunoproteasomes in inflammation as well as the spectrum of autoinflammatory diseases.

References

Aug 26, 1994·Science·H J FehlingH von Boehmer
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A J SijtsP M Kloetzel
Jan 13, 2001·Current Opinion in Immunology·J W Yewdell, J R Bennink
Jan 22, 2004·Current Opinion in Immunology·Peter Michael Kloetzel, Ferry Ossendorp
Mar 3, 2004·Nature Reviews. Molecular Cell Biology·Cecile M Pickart, Robert E Cohen
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Aaron Ciechanover
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Jan 5, 2008·Annual Review of Immunology·Mary E KeirArlene H Sharpe
Mar 26, 2008·Nature Reviews. Immunology·Jenny P-Y TingDaniel T Bergstralh
Aug 14, 2008·Nature Reviews. Molecular Cell Biology·Tommer Ravid, Mark Hochstrasser
Jan 6, 2009·Immunological Reviews·Mohamed Lamkanfi, Vishva M Dixit
Jan 24, 2009·Nature Reviews. Molecular Cell Biology·Shigeo MurataKeiji Tanaka
Feb 19, 2009·Current Opinion in Immunology·Siamon Gordon, Giorgio Trinchieri
Jun 6, 2009·Annual Review of Biochemistry·Daniel Finley
Dec 5, 2009·Nature Reviews. Immunology·Ira Tabas
Dec 17, 2009·Nature Reviews. Immunology·Marcus GroettrupMichael Basler
Mar 23, 2010·Cell·Osamu Takeuchi, Shizuo Akira
Mar 24, 2010·Annual Review of Immunology·Kenneth L RockHajime Kono
Jun 8, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michael BaslerChristopher J Kirk
Jun 11, 2010·The Journal of Clinical Endocrinology and Metabolism·Abhimanyu GargOralia Barboza
Jul 31, 2010·Current Opinion in Rheumatology·Cailin Henderson, Raphaela Goldbach-Mansky
Aug 21, 2010·Cell·Sjoerd van Deventer, Jacques Neefjes
Oct 15, 2010·Nature Reviews. Molecular Cell Biology·Jens TyedmersBernd Bukau
Nov 30, 2010·Cell·Michael J Clague, Sylvie Urbé
Jan 12, 2011·Annual Review of Immunology·Beckley K DavisJenny P-Y Ting
Jan 15, 2011·Nature Reviews. Immunology·Marc Y Donath, Steven E Shoelson

❮ Previous
Next ❯

Citations

Jan 5, 2021·The Journal of Clinical Endocrinology and Metabolism·Dongyi WanGuopeng Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Ryuta Nishikomori
Progress in Molecular Biology and Translational Science
Deborah A Ferrington, Dale S Gregerson
Current Opinion in Rheumatology
John G Ryan, Raphaela Goldbach-Mansky
Inflammation and Regeneration
Hideki ArimochiKoji Yasutomo
© 2022 Meta ULC. All rights reserved